We All Have Cancer, But How Much? – iHealthTube18

Ed Park, MD #webinarwednesday, dr ed park, ihealthtube 0 Comments

For today’s #WebinarWednesday, we return to the penultimate iHealthTube video interview that I did at the 2013 American Academy of Anti-Aging Medicine.  I explain why we are like cars and that with time, if we survive all our cancers, we would eventually accumulate them all. Just like if you drive a car for millions of miles, you will replace all parts.

My belief is that replicative senescence, or the shortening of telomeres, can account for most cancers.  Family history is indicated in very few cases and for the most part, they involve failure of DNA repair or cell suicide pathways.  A landmark study in the Journal of the AMA suggests that indeed, all cancers are related to telomere shortening in a dose-dependen fashion: http://www.ncbi.nlm.nih.gov/pubmed/20606151


We all have cancer.- iHealthtube 18


Follow me

Ed Park, MD

I graduated from Harvard with honors in Biological Anthropology prior to earning my Medical Degree and Masters in Public Health from Columbia University.

In 2007, I became the nineteenth patient to sign up for the use of a herbally-extracted telomerase activator.

The results were so positive that I founded Recharge Biomedical Clinic in 2008 and have since become the leading medical expert in this exciting new field of regenerative medicine treating over 1,300 patients with this exciting new telomerase activation medicine.

I won two Houston Film Festival Awards for my screenplays about Hypatia of Alexandria and Ed Brown of Kentucky.

In 2010 I wrote and self-published a Sci-Fi Graphic Novel called MAXIMUM LIFESPAN

In 2013, I wrote and published "Telomere Timebombs; Defusing the Terror of Aging"

My websites are:
http://www.lokahi.guru (where you can learn about my RECHARGE adaptogenic supplement)
http://www.rechargebiomedical.com and

You can sign up for my weekly blogs on this page and subscribe to my YouTube videos at https://www.youtube.com/drpark65
Follow me

Facebook Comments (0)

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *